BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Concordia International Corp. Announces First Quarter 2018 Results

  First quarter 2018 revenue of $152 million

  May 15, 2018

   · 

  34 min read
• Business

  Cronos Group Inc. Announces First Quarter 2018 Results

  Q1 2018 total sales of $2.9 million, up 473% year over year

  May 15, 2018

   · 

  5 min read
• Business

  Alnylam Appoints Colleen Reitan to the Board of Directors

  Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the appointment of a veteran healthcare leader, Colleen Reitan, to Alnylam’s Board of Directors, effective June 1, 2018.

  May 15, 2018

   · 

  5 min read
• Business

  GTx Provides Corporate Update and Reports First Quarter 2018 Financial Results

  Top-line results from the ASTRID Trial expected early in the fourth quarter of 2018

  May 15, 2018

   · 

  9 min read
• Business

  Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. Food and Drug Administration Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient Advocacy

  Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced the appointment of Gayatri R. Rao, M.D., J.D., as Vice President, Regulatory Policy and Patient Advocacy.

  May 15, 2018

   · 

  3 min read
• Business

  Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

  Treated first subject in clinical trials of two Synthetic BioticTM medicines, SYNB1020 and SYNB1618; both studies expected to generate data in 2018

  May 15, 2018

   · 

  8 min read
• Business

  Acerus Reports First Quarter 2018 Financial Results

  Product revenues increased 60% to $1.6 million versus $1.0 million in the same prior year period

  May 15, 2018

   · 

  10 min read
• Business

  Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update

  TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track

  May 15, 2018

   · 

  6 min read
• Biotech Beach

  Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

  Investment will enable Surface to fund its development programs focused on FDA approval of its ocular disease drug candidates

  May 15, 2018

   · 

  6 min read
• Business

  Aldeyra Therapeutics Announces First Quarter 2018 Financial Results

  Aldeyra is a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases

  May 15, 2018

   · 

  16 min read